Myeloma cells act as tolerogenic antigen-presenting cells and induce regulatory T cellsin vitro-Reference-Cited by-同舟云学术

Myeloma cells act as tolerogenic antigen-presenting cells and induce regulatory T cellsin vitro

Published:2015-02-23 Issue:1 Volume:95 Page:65-74
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Frassanito Maria Antonia¹,Ruggieri Simona²,Desantis Vanessa³,Di Marzo Lucia³,Leone Patrizia³,Racanelli Vito³,Fumarulo Ruggiero¹,Dammacco Franco³,Vacca Angelo³

Affiliation:

1. General Pathology Unit; Department of Biomedical Sciences and Human Oncology; University of Bari Medical School; Bari Italy

2. Department of Human Anatomy, Histology and Embryology; University of Bari Medical School; Bari Italy

3. Section of Internal Medicine and Clinical Oncology; Department of Biomedical Sciences and Human Oncology; University of Bari Medical School; Bari Italy

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12481/fullpdf

Reference40 articles.

1. Thymic regulatory T cells;Maggi;Autoimmun Rev,2005

2. Regulatory T cells and transplantation tolerance;Jiang;Hum Immunol,2006

3. Regulatory T cells and cancer;Wang;Curr Opin Immunol,2007

4. Tregs and rethinking cancer immunotherapy;Curiel;J Clin Invest,2007

5. Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes;Cosmi;Blood,2003

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in microenvironment-based therapies: transforming the landscape of multiple myeloma treatment;Frontiers in Oncology;2024-07-17

2. KDM6A Regulates Immune Response Genes in Multiple Myeloma;2024-02-12

3. What happens to regulatory T cells in multiple myeloma;Cell Death Discovery;2023-12-21

4. Characterization of monoclonal gammopathy of undetermined significance progression to multiple myeloma through meta-analysis of GEO data;Heliyon;2023-07

5. Contribution of the Tumor Microenvironment to Metabolic Changes Triggering Resistance of Multiple Myeloma to Proteasome Inhibitors;Frontiers in Oncology;2022-05-26